Healthcare Triangle Inc is expected to report a Q2 2026 consensus revenue of $10.35 million and an EPS of -$3.43, with its current stock price of $1.19 trading well below the average analyst price target of $3.21.
Investors are primarily focused on the adoption rate and revenue contribution from the company's AI-driven platforms, such as CloudEz and the recently launched Agentic AI platform.
The company is looking to build on strong Q1 momentum, where it saw 166% revenue growth following the strategic acquisitions of Teyame 360 and Datono. Analysts are specifically monitoring whether these high-margin digital transformation services can significantly narrow operating losses and improve the long-term cash flow profile.